From the ∗Department of Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany

†Institute of Diagnostic and Interventional Radiology, Technical University of Munich, School of Medicine, Munich, Germany

‡Philips GmbH, Hamburg, Germany

§Department of Radiology and Nuclear Medicine, University Medical Center Mannheim, Germany

∥Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Switzerland

¶Institute of Diagnostic and Interventional Radiology, University Hospital of Cologne, Cologne, Germany

#Institute of Diagnostic and Interventional Radiology, University Hospital of Frankfurt, Frankfurt, Germany

∗∗Institute of Diagnostic and Interventional Radiology, University Hospital Würzburg, Würzburg, Germany.

Received for publication June 15, 2022; and accepted for publication, after revision, July 31, 2022.

Conflicts of interest and sources of funding: The authors received funding from Deutsche Forschungsgemeinschaft/German Research Foundation (DFG) through grant 428149221. Wichtmann has given scientific presentations for Philips GmbH and the Bender group/b.e.imaging GmbH on unrelated topics for which monetary compensation was received. In addition, Weiss is working for Philips GmbH.

Correspondence to: Barbara D. Wichtmann, MD, MSc, Department of Radiology, University Hospital Bonn, Venusberg-Campus 1, D-53127 Bonn, Germany. E-mail: [email protected].

Supplemental digital contents are available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.investigativeradiology.com).